FDA Adverse Event Malfunction Summary report: N

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

MDR report key: 6182344 · Received December 16, 2016

Report

Report Number
2032227-2016-50505
Event Type
Malfunction
Date Received
December 16, 2016
Date of Event
November 21, 2016
Report Date
January 13, 2017
Manufacturer
MEDTRONIC PUERTO RICO OPERATIONS CO.
Product Code
OYC
PMA / PMN Number
P980022
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. THIS MDR RELATED TO THE (B)(4) MANUFACTURING SITE HAS BEEN ASSIGNED A MEDWATCH NUMBER FROM THE MEDTRONIC MINIMED NORTHRIDGE SITE, PER VARIANCE 5.

Additional Manufacturer Narrative · 1

THE INSULIN PUMP WAS RECEIVED WITH BLANK DISPLAY DUE TO COLD SOLDER JOINT OF U4 AND U7 ON THE MOTHER BOARD. THE INSULIN PUMP HAD CRACKED CASE AT THE DISPLAY WINDOW CORNER, MINOR SCRATCHED LCD WINDOW AND CRACKED RESERVOIR TUBE LIP.

Description of Event or Problem · 1

THE CUSTOMER REPORTED VIA PHONE CALL OF A BLANK DISPLAY FROM THE INSULIN PUMP. THE CUSTOMER'S BLOOD GLUCOSE LEVEL WAS UNKNOWN. THE CUSTOMER STATED THAT THE PUMP HAS NOT BEEN DROPPED OR BUMPED. THE CUSTOMER STATED THAT THE PUMP WAS NOT EXPOSED TO MOISTURE. THE CUSTOMER WAS ADVISED TO INSERT NEW (B)(4) BATTERIES. THE CUSTOMER STATED THAT THE DISPLAY DID NOT RETURN. THE CUSTOMER WAS ADVISED TO DISCONTINUE USE OF THE DEVICE AND REVERT TO A BACKUP PLAN PER HEALTH CARE PROVIDER'S INSTRUCTIONS. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
833503 PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP INSULIN INFUSION PUMP / SENSOR AUGMENTED OYC MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-723NAP

Patients

Seq Age Sex Outcome Treatment
1 24 YR